[1] OTITE FO, KHANDELWAL P, MALIK AM, et al.Ten-year temporal trends in medical complications after acute intracerebral hemorrhage in the United States[J].Stroke, 2017, 48(3):596. doi: 10.1161/STROKEAHA.116.015746
[2] CHENG X, ZHANG L, XIE NC, et al.High plasma levels of D-Dimer are independently associated with a heightened risk of deep vein thrombosis in patients with intracerebral hemorrhage[J].Mol Neurobiol, 2016, 53(8):5671. doi: 10.1007/s12035-015-9487-5
[3] 穆景颂, 倪朝民, 吴鸣, 等.脑出血病人下肢深静脉血栓形成的危险因素分析[J].中华物理医学与康复杂志, 2018, 40(12):906. doi: 10.3760/cma.j.issn.0254-1424.2018.12.007
[4] 马玉娟, 曹留拴, 蔡西国, 等.早期脊髓损伤病人下肢深静脉血栓形成的危险因素分析[J].中华物理医学与康复杂志, 2014, 36(12):918.
[5] GOLDHABER SZ.Risk factors for venous thromboembolism[J].J Am Coll Cardiol, 2010, 56(1):1. doi: 10.1016/j.jacc.2010.01.057
[6] GUO X, ZHANG F, WU Y, et al.Coagulation alternation and deep venous thrombosis in brain tumor patients during the perioperative period[J].World Neurosurg, 2018, 114:e982. doi: 10.1016/j.wneu.2018.03.128
[7] PIAZZA G, GOLDHABER SZ.Venous thromboembolism and atherothrombosis:an integrated approach[J].Circulation, 2010, 121(19):2146. doi: 10.1161/CIRCULATIONAHA.110.951236
[8] AGENO W, BECATTINI C, BRIGHTON T, et al.Cardiovascular risk factors and venous thromboembolism:a meta-analysis[J].Circulation, 2008, 117(1):93. doi: 10.1161/CIRCULATIONAHA.107.709204
[9] STEFFEN LM, CUSHMAN M, PEACOCK JM, et al.Metabolic syndrome and risk of venous thromboembolism:longitudinalinvestigation of thromboembolism etiology[J].J Thromb Haemost, 2009, 7(5):746. doi: 10.1111/j.1538-7836.2009.03295.x
[10] HARDMAN RL.Management of chronic deep vein thrombosis in women[J].Semin Intervent Radiol, 2018, 35(1):3. doi: 10.1055/s-0038-1636514
[11] KAWASE K, OKAZAKI S, TOYODA K, et al.Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage[J].Cerebrovasc Dis, 2009, 27(4):313. doi: 10.1159/000202006
[12] CUSHMAN M, GLYNN RJ, GOLDHABER SZ, et al.Hormonal factors and risk of recurrent venous thrombosis:the prevention of recurrent venous thromboembolism trial[J].J Thromb Haemost, 2006, 4(10):2199. doi: 10.1111/j.1538-7836.2006.02140.x
[13] MOUSSOUTTAS M, BHATNAGER M, HUYNH TT, et al.Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage[J].Acta Neurochir (Wien), 2013, 155(8):1501. doi: 10.1007/s00701-013-1725-x
[14] ENGBERS MJ, VAN HYLCKAMA VLIEG A, ROSENDAAL FR.Venousthrombosis in the elderly:incidence, risk factors and risk groups[J].J Thromb Haemost, 2010, 8(10):2105. doi: 10.1111/j.1538-7836.2010.03986.x
[15] ENGBERS MJ, BLOM JW, CUSHMAN M, et al.The contribution of immobility risk factors to the incidence of venous thrombosis in an older population[J].J Thromb Haemost, 2014, 12(3):290. doi: 10.1111/jth.12480
[16] KUWASHIRO T, TOYODA K, OYAMA N, et al.High plasma D-dimer is a marker of deep vein thrombosis in acute stroke[J].J Stroke Cerebrovasc Dis, 2012, 21(3):205. doi: 10.1016/j.jstrokecerebrovasdis.2010.06.009
[17] FOLSOM AR, LUTSEY PL, ASTOR BC, et al.C-reactive protein and venous thromboembolism.A prospective investigation in the ARIC cohort[J].Thromb Haemost, 2009, 102(4):615.